Hypertrophic obstructive cardiomyopathy in the era of cardiac MRI.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15156009)

Published in J Invasive Cardiol on June 01, 2004

Authors

Muhammad U Mustafa1, Chunguang Chen, Marc Cohen

Author Affiliations

1: Department of Cardiology, Newark Beth Israel Medical Center, Newark, New Jersey 07039, USA. usmanmustafa@yahoo.com

Articles by these authors

(truncated to the top 100)

Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med (2015) 8.69

Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med (2010) 7.39

Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med (2006) 5.07

Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA (2011) 3.28

Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med (2010) 3.05

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA (2004) 2.89

A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. Circ Heart Fail (2011) 2.15

The use of virtual patients to teach medical students history taking and communication skills. Am J Surg (2006) 1.84

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet (2011) 1.80

Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol (2003) 1.68

Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovasc Interv (2002) 1.66

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv (2009) 1.56

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA (2005) 1.52

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ (2012) 1.51

Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol (2007) 1.51

Analysis of particulate debris after superficial femoral artery atherectomy. J Invasive Cardiol (2009) 1.50

Pitfalls associated with the use of current recommendations for fluoroscopy-guided common femoral artery access. Catheter Cardiovasc Interv (2013) 1.47

Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. Int J Cardiol (2009) 1.45

Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial. JAMA (2013) 1.45

Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA (2004) 1.44

Internet-based health promotion and disease control in the 8 cities: successes, barriers, and future plans. Sex Transm Dis (2005) 1.41

Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J (2003) 1.21

DNA damage and repair in human oocytes and embryos: a review. Zygote (2010) 1.11

Yoga in Australia: Results of a national survey. Int J Yoga (2012) 1.07

Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg (2002) 1.05

Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery. Ann Thorac Surg (2002) 1.05

C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proc Natl Acad Sci U S A (2005) 1.04

Do medical students respond empathetically to a virtual patient? Am J Surg (2007) 1.04

Staphylococcus capitis prosthetic valve endocarditis: report of two rare cases and review of literature. Heart Lung (2008) 0.97

Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention. Int J Cardiol (2010) 0.95

Yoga and hypertension: a systematic review. Altern Ther Health Med (2014) 0.91

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study. J Am Coll Cardiol (2003) 0.90

Right heart complications of dual lumen tunneled venous catheters in hemodialysis patients. Am J Med Sci (2005) 0.90

Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Am Heart J (2003) 0.89

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. Am Heart J (2006) 0.89

Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Catheter Cardiovasc Interv (2007) 0.89

Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. J Am Coll Cardiol (2013) 0.88

Efficacy and Safety of a Chinese Herbal Medicine Formula (RCM-104) in the Management of Simple Obesity: A Randomized, Placebo-Controlled Clinical Trial. Evid Based Complement Alternat Med (2012) 0.87

Uptake and impact of research for evidence-based practice: lessons from the Africa Health Systems Initiative Support to African Research Partnerships. BMC Health Serv Res (2014) 0.87

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J (2007) 0.87

Remodeling of small intramyocardial coronary arteries distal to a severe epicardial coronary artery stenosis. Arterioscler Thromb Vasc Biol (2002) 0.87

The practice and regulatory requirements of naturopathy and western herbal medicine in Australia. Risk Manag Healthc Policy (2009) 0.86

Molecular effects of fractional carbon dioxide laser resurfacing on photodamaged human skin. Arch Facial Plast Surg (2010) 0.86

Genetic modification of cells for transplantation. Adv Drug Deliv Rev (2007) 0.85

Garlic for the common cold. Cochrane Database Syst Rev (2009) 0.85

Autism, imprinting and epigenetic disorders: a metabolic syndrome linked to anomalies in homocysteine recycling starting in early life?? J Assist Reprod Genet (2011) 0.85

Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial. Eur Heart J (2008) 0.85

Effect of antioxidants on sperm genetic damage. Adv Exp Med Biol (2014) 0.85

Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction. Am J Cardiol (2013) 0.84

Relationships between measures of dysfunctional breathing in a population with concerns about their breathing. J Bodyw Mov Ther (2010) 0.84

In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. Am J Cardiol (2004) 0.84

Evaluation of breathing pattern: comparison of a Manual Assessment of Respiratory Motion (MARM) and respiratory induction plethysmography. Appl Psychophysiol Biofeedback (2008) 0.83

Relationship between dysfunctional breathing patterns and ability to achieve target heart rate variability with features of "coherence" during biofeedback. Altern Ther Health Med (2011) 0.83

Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J Gen Intern Med (2008) 0.82

Garlic for the common cold. Cochrane Database Syst Rev (2014) 0.82

Characteristics and consumption patterns of Australian organic consumers. J Sci Food Agric (2012) 0.82

Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. Am Heart J (2002) 0.82

Radiologic measurement of submandibular gland ptosis. Facial Plast Surg (2013) 0.81

Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome. Am Heart J (2008) 0.81

The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures. J Thromb Thrombolysis (2006) 0.81

Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin (2006) 0.81

Addressing the human resources for health crisis through task-shifting and retention: results from the Africa Health Systems Initiative Support to African Research Partnerships program. Hum Resour Health (2014) 0.81

Yoga for improving sleep quality and quality of life for older adults. Altern Ther Health Med (2014) 0.81

Garlic for the common cold. Cochrane Database Syst Rev (2012) 0.81

The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy. Am Heart J (2006) 0.80

Balancing myocardial ischemic and bleeding risks in patients with non-ST-segment elevation myocardial infarction. Am J Cardiol (2009) 0.80

Sperm nucleus decondensation, hyaluronic acid (HA) binding and oocyte activation capacity: different markers of sperm immaturity? Case reports. J Assist Reprod Genet (2012) 0.80

Multivessel off-pump revascularization in octogenarians: early and midterm outcomes. Ann Thorac Surg (2003) 0.80

The anatomy of nasopharyngeal carcinoma spread through the pharyngobasilar fascia to the trigeminal mandibular nerve on 1.5 T MRI. Surg Radiol Anat (2010) 0.79

Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen. J Thromb Thrombolysis (2008) 0.79

Randomized trial of tacrolimus monotherapy: tacrolimus in combination, tacrolimus alone compared (the TICTAC trial). J Heart Lung Transplant (2007) 0.79

Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention. Am J Cardiol (2002) 0.79

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Circulation (2002) 0.79

Activation of NFκB dependent apoptotic pathway in pancreatic islet cells by hypoxia. Islets (2010) 0.79

A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial). Am J Cardiol (2013) 0.79

Preoperative IABP in high-risk patients reduces postoperative lactate release and subsequent mortality. Ann Thorac Surg (2002) 0.78

Surgical treatment of a clival-C2 atypical teratoid/rhabdoid tumor. J Neurosurg Pediatr (2010) 0.78

Malonaldehyde formation and DNA fragmentation: two independent sperm decays linked to reactive oxygen species. Zygote (2010) 0.78

Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies. J Am Coll Cardiol (2003) 0.78

Association of carotid artery intima-media thickness with complex aortic atherosclerosis in patients with recent stroke. Angiology (2002) 0.78

A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial. Am Heart J (2011) 0.78

The importance of the one carbon cycle nutritional support in human male fertility: a preliminary clinical report. Reprod Biol Endocrinol (2014) 0.78

Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus. Am Heart J (2002) 0.78

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis. Vasc Health Risk Manag (2012) 0.78

Platelets and antiplatelet therapy in patients with diabetes mellitus. J Invasive Cardiol (2003) 0.78

Interatrial thrombus-in-transit resulting in paradoxical thromboembolism. J Thromb Thrombolysis (2009) 0.78

Disease relapse after segmental resection and free flap reconstruction for mandibular osteoradionecrosis. Otolaryngol Head Neck Surg (2010) 0.78

Assessing diet as a modifiable risk factor for pesticide exposure. Int J Environ Res Public Health (2011) 0.77

Enoxaparin: a pharmacologic and clinical review. Expert Opin Pharmacother (2011) 0.77

Investigating the claims of Konstantin Buteyko, M.D., Ph.D.: the relationship of breath holding time to end tidal CO2 and other proposed measures of dysfunctional breathing. J Altern Complement Med (2008) 0.76

Use of complementary medicines by cardiac surgery patients; undisclosed and undetected. Heart Lung Circ (2011) 0.76

Unfractionated versus fractionated heparin for percutaneous coronary intervention. Curr Cardiol Rep (2002) 0.76

Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report. J Invasive Cardiol (2006) 0.76

Exploring the other side of acupuncture. J Altern Complement Med (2006) 0.75

Appropriate anti-thrombotic/anti-thrombin therapy for thrombotic lesions. Curr Cardiol Rev (2012) 0.75

Response to "Parathyroid Surgery: Getting It Right the First Time": Parathyroid Surgery: Primum Non Nocere. Otolaryngol Head Neck Surg (2016) 0.75

Progress with diabetic patients undergoing percutaneous coronary intervention. Eur Heart J (2004) 0.75

Utility of carotid duplex ultrasonography in a general inner-city hospital. Cardiovasc Ultrasound (2014) 0.75

Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation. Thromb Haemost (2002) 0.75